691 related articles for article (PubMed ID: 34657143)
1. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.
Andersen JV; Skotte NH; Christensen SK; Polli FS; Shabani M; Markussen KH; Haukedal H; Westi EW; Diaz-delCastillo M; Sun RC; Kohlmeier KA; Schousboe A; Gentry MS; Tanila H; Freude KK; Aldana BI; Mann M; Waagepetersen HS
Cell Death Dis; 2021 Oct; 12(11):954. PubMed ID: 34657143
[TBL] [Abstract][Full Text] [Related]
2. Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease.
Andersen JV; Christensen SK; Westi EW; Diaz-delCastillo M; Tanila H; Schousboe A; Aldana BI; Waagepetersen HS
Neurobiol Dis; 2021 Jan; 148():105198. PubMed ID: 33242587
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Cerebral Cortical Glucose and Glutamine Metabolism Precedes Amyloid Plaques in the APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease.
Andersen JV; Christensen SK; Aldana BI; Nissen JD; Tanila H; Waagepetersen HS
Neurochem Res; 2017 Jun; 42(6):1589-1598. PubMed ID: 27686658
[TBL] [Abstract][Full Text] [Related]
4. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
[TBL] [Abstract][Full Text] [Related]
5. Conditional BDNF Delivery from Astrocytes Rescues Memory Deficits, Spine Density, and Synaptic Properties in the 5xFAD Mouse Model of Alzheimer Disease.
de Pins B; Cifuentes-Díaz C; Farah AT; López-Molina L; Montalban E; Sancho-Balsells A; López A; Ginés S; Delgado-García JM; Alberch J; Gruart A; Girault JA; Giralt A
J Neurosci; 2019 Mar; 39(13):2441-2458. PubMed ID: 30700530
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology.
Hong I; Kang T; Yoo Y; Park R; Lee J; Lee S; Kim J; Song B; Kim SY; Moon M; Yun KN; Kim JY; Mook-Jung I; Park YM; Choi S
J Alzheimers Dis; 2013; 36(2):321-34. PubMed ID: 23603400
[TBL] [Abstract][Full Text] [Related]
7. Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFAD mice, an animal model of Alzheimer's disease.
Moon M; Jeong I; Kim CH; Kim J; Lee PK; Mook-Jung I; Leblanc P; Kim KS
J Neurochem; 2015 Jan; 132(2):254-62. PubMed ID: 25156412
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte energy and neurotransmitter metabolism in Alzheimer's disease: Integration of the glutamate/GABA-glutamine cycle.
Andersen JV; Schousboe A; Verkhratsky A
Prog Neurobiol; 2022 Oct; 217():102331. PubMed ID: 35872221
[TBL] [Abstract][Full Text] [Related]
9. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
10. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
[TBL] [Abstract][Full Text] [Related]
11. PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease.
Giralt A; de Pins B; Cifuentes-Díaz C; López-Molina L; Farah AT; Tible M; Deramecourt V; Arold ST; Ginés S; Hugon J; Girault JA
Exp Neurol; 2018 Sep; 307():62-73. PubMed ID: 29803828
[TBL] [Abstract][Full Text] [Related]
12. A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse.
López-Gambero AJ; Rosell-Valle C; Medina-Vera D; Navarro JA; Vargas A; Rivera P; Sanjuan C; Rodríguez de Fonseca F; Suárez J
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065168
[TBL] [Abstract][Full Text] [Related]
13. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
Katsouri L; Georgopoulos S
PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
[TBL] [Abstract][Full Text] [Related]
14. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease.
Pilat D; Paumier JM; García-González L; Louis L; Stephan D; Manrique C; Khrestchatisky M; Di Pasquale E; Baranger K; Rivera S
J Neuroinflammation; 2022 Mar; 19(1):65. PubMed ID: 35277173
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte remodeling in the beneficial effects of long-term voluntary exercise in Alzheimer's disease.
Belaya I; Ivanova M; Sorvari A; Ilicic M; Loppi S; Koivisto H; Varricchio A; Tikkanen H; Walker FR; Atalay M; Malm T; Grubman A; Tanila H; Kanninen KM
J Neuroinflammation; 2020 Sep; 17(1):271. PubMed ID: 32933545
[TBL] [Abstract][Full Text] [Related]
16. Stable isotope tracing reveals disturbed cellular energy and glutamate metabolism in hippocampal slices of aged male mice.
McNair LM; Andersen JV; Waagepetersen HS
Neurochem Int; 2023 Dec; 171():105626. PubMed ID: 37838084
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease.
Davis N; Mota BC; Stead L; Palmer EOC; Lombardero L; Rodríguez-Puertas R; de Paola V; Barnes SJ; Sastre M
J Neuroinflammation; 2021 Mar; 18(1):73. PubMed ID: 33731156
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Colony-Stimulating Factor 1 Receptor by PLX3397 Prevents Amyloid Beta Pathology and Rescues Dopaminergic Signaling in Aging 5xFAD Mice.
Son Y; Jeong YJ; Shin NR; Oh SJ; Nam KR; Choi HD; Choi JY; Lee HJ
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756440
[TBL] [Abstract][Full Text] [Related]
19. Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.
Demarest TG; Varma VR; Estrada D; Babbar M; Basu S; Mahajan UV; Moaddel R; Croteau DL; Thambisetty M; Mattson MP; Bohr VA
Acta Neuropathol; 2020 Jul; 140(1):25-47. PubMed ID: 32333098
[TBL] [Abstract][Full Text] [Related]
20. Synaptosomal Mitochondrial Dysfunction in 5xFAD Mouse Model of Alzheimer's Disease.
Wang L; Guo L; Lu L; Sun H; Shao M; Beck SJ; Li L; Ramachandran J; Du Y; Du H
PLoS One; 2016; 11(3):e0150441. PubMed ID: 26942905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
